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in bone tissue engineering and regenerative medicine.[1] Tre-
mendous advancements have been made in tailoring bone 
biomaterials to modulate stem cell fates, based on two gen-
eral strategies: (1) modulation of the physical and chemical 
properties of biomaterial surfaces,[2] and (2) incorporation of 
Understanding cell–biomaterial interactions is critical for the control of cell fate for tissue engineering and regenerative 
medicine. Here, cerium oxide nanoparticles (CeONPs) are applied at different Ce4+/Ce3+ ratios (i.e., 0.46, 1.23, and 3.23) to 
titanium substrate surfaces by magnetron sputtering and vacuum annealing. Evaluation of the cytotoxicity of the modified 
surface to cultured rat bone marrow mesenchymal stem cells (BMSCs) reveals that the cytocompatibility and cell prolifera-
tion are proportional to the increases in Ce4+/Ce3+ ratio on titanium surface. The bone formation capability induced by these 
surface modified titanium alloys is evaluated by implanting various CeONP samples into the intramedullary cavity of rat 
femur for 8 weeks. New bone formation adjacent to the implant shows a close relationship to the surface Ce4+/Ce3+ ratio; 
higher Ce4+/Ce3+ ratio achieves better osseointegration. The mechanism of this in vivo outcome is explored by culturing 
rat BMSCs and RAW264.7 murine macrophages on CeONP samples for different durations. The improvement in osteo-
genic differentiation capability of BMSCs is directly proportional to the increased Ce4+/Ce3+ ratio on the titanium surface. 
Increases in the Ce4+/Ce3+ ratio also elevate the polarization of the M2 phenotype of RAW264.7 murine macrophages, par-
ticularly with respect to the healing-associated M2 percentage and anti-inflammatory cytokine secretion. The manipulation 
of valence states of CeONPs appears to provide an effective modulation of the osteogenic capability of stem cells and the 
M2 polarization of macrophages, resulting in favorable outcomes of new bone formation and osseointegration.
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1. Introduction
Understanding the interactions between stem cells and bio-
materials surface is essential for controlling stem cell fates, 
including adhesion, proliferation, and osteogenic differentiation, 
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bioactive cues onto biomaterial surfaces.[3] For instance, elec-
troactive biomaterials have been designed to stimulate the 
osteogenesis of stem cell, thereby inducing subsequent bone 
regeneration. As inspired by the piezoelectric property of 
bones, Yu et al. designed the microscale piezoelectric zones 
(MPZs) with the use of K0.5Na0.5NbO3 ceramics to guide the 
stem cell osteogenic differentiation in vitro and in vivo.[4] 
Indeed, when an inverse piezoelectric effect was introduced 
to bone, the strain induced in bone matrix could stimulate the 
cellular activity of bone cells and then improved bone regen-
eration.[5] When low-intensity pulsed ultrasound (LIPUS) was 
applied to porous titanium alloy scaffold, the micro mechanical 
strain induced by LIPUS would therefore initiate osteoblastic 
differentiation, bone formation and maturation as well as bony 
ingrowth in the porous scaffold.[6] A recent study by Ning et al. 
proposed the use of periodic microscale electric field (MEF) to 
induce bone-implant integration. Two parallel semiconducted 
anatase and rutile TiO2 zones were established on titanium 
implant and this electrical cue was able to direct stem cell 
osteogenic differentiation and bone regeneration on implant 
surface.[7] However, identification of the influences of specific 
surface features of biomaterials on stem cell functions remains 
difficult due to the substrate complexity, and the mechanism 
underlying their interaction is still not well understood. None-
theless, macrophages appear to play a critical role in host reac-
tions in the early stage of bone biomaterial insertion, and their 
initial response to a biomaterial can determine the success of 
biomaterial-associated osteogenesis.[1b,8]
In response to various tissue microenvironmental cues, 
highly plastic macrophages can alter their phenotypes and 
functions to display the classically activated proinflammatory 
M1 and alternatively activated antiinflammatory M2 forms.[9] 
The prohealing M2-polarized macrophage phenotype can 
elicit positive outcomes on osteogenesis, angiogenesis, and 
osseointegration,[8a,10] and macrophage polarization can be 
modulated by the surface physics and chemistry cues of bone 
biomaterials. Therefore, modulation of the macrophage polari-
zation response to biomaterials may be a promising strategy for 
eliciting favorable outcomes for bone tissue engineering and 
regenerative medicine.[11]
In fact, as a foreign body, a biomaterial implant is recognized 
by the host immune system and triggers an immune reac-
tion that may eventually determine the in vivo fate of the bone 
biomaterials.[11f,12] Introduction of an implant into the body ini-
tiates an inflammatory cascade due to cell and tissue damage, 
and this cascade persists for roughly 4 d.[13] This early inflamma-
tory response is beneficial to the host, but termination of subse-
quent inflammation is critical for blocking tissue damage and 
promoting tissue regeneration.[14] Therefore, an in-depth under-
standing of the mechanism underlying the immune response 
mediated by a bone biomaterial would aid in the development of 
novel bone biomaterials that can create a favorable local immune 
environment for optimal osteogenesis and osseointegration.
Recently, cerium oxide nanoparticles (CeONPs) have 
attracted increasing interest for biological applications because 
of their excellent catalytic activities, which arise from quick 
and expedient switches in oxidation state between Ce4+ (CeO2) 
and Ce3+ (Ce2O3) during redox reactions.[15] In particular, their 
capability to quench free radicals (i.e., antioxidant activity) give 
CeONPs great potential for use in therapy of diseases caused by 
reactive oxygen species (ROS), such as retinal degeneration,[16] 
cardiovascular pathology,[17] neurodegenerative disorders,[18] 
and spinal cord injury.[19] Most of the CeONP characteristics 
are endowed by the co-existence of both Ce4+ and Ce3+ oxida-
tion states. In addition, nano-CeO2 regions promote cell prolif-
eration on a functionalized polymer scaffold surface, whereas 
nano-Ce2O3 regions have an inhibitory effect on cell prolifera-
tion.[20] CeO2 nanoparticles can also induce aligned growth of 
stem cells and improve the bioactivity of polymer scaffold sur-
faces.[21] They also show favorable biocompatibility and exert a 
protective effect on normal cells even at levels that exhibit anti-
tumor effects on cancer cells.[22]
This mixed valence state of CeONPs has therapeutic poten-
tial due to the possibility of scavenging ROS in cells.[16,23] Pre-
vious in vitro studies have shown that CeONPs can react cata-
lytically with superoxide and hydrogen peroxide to mimic the 
biological actions of superoxide dismutase (SOD)[23b,24] and 
catalase.[25] At physiological pH, in particular, Ce3+ and Ce4+ 
sites on CeONP surfaces show this SOD and catalase mimetic 
activity, respectively.[15] For these reasons, CeONPs supplied to 
murine J774A.1 macrophages can scavenge ROS and inhibit 
inflammatory mediator production.[26] These significant advan-
tages of CeONPs support the speculation that CeONPs could be 
useful in modifying bone biomaterials to impart immunomod-
ulatory characteristics that will allow regulation of macrophage 
behavior and promotion of stem cell osteogenic differentiation 
and bone tissue regeneration.
Nevertheless, few designs that have immobilized CeONPs 
onto bone biomaterials have also demonstrated immunomod-
ulatory and osteogenic-inducing activity. Titanium-based bio-
materials are widely applied in orthopedic and dental implants 
due to their desirable biocompatibility and mechanical prop-
erties.[27] However, their bioactivity is insufficient in terms of 
bone-implant osseointegration and fibrotic scarring medi-
ated by macrophages is usually found during foreign body 
response.[28] Therefore, the aim of this study was to design a 
functional titanium surface that is able to modulate the mac-
rophage immune response and the osteogenic capability of 
stem cells, followed by stimulation of bone tissue regeneration. 
A promising strategy to achieve this goal would appear to be 
modulation of the Ce valence states of extracellular CeONPs.
The biofunction of Ce4+ and Ce3+ particles is size dependent, 
and the fraction of Ce4+ in particles generally increases with 
increases in the particle size.[29] Hence, a magnetron sput-
tering technique was adopted to control the particle size and 
the Ce4+/Ce3+ ratio of CeONPs was optimized by deposition 
time. We hypothesized that this functional surface with its 
higher Ce4+/Ce3+ ratio can effectively modulate macrophage 
behavior, thereby promoting new bone formation. Following 
characterization of the physical and chemical properties 
of the CeONP-modified titanium surface, the cytocompat-
ibility of this surface was tested by culturing rat bone marrow 
mesenchymal stem cells (BMSCs), with subsequent in vivo 
animal implantation for osteogenic capability assessment. 
The detailed biological responses and underlying mechanism 
of new bone formation were investigated by culturing, rat 
BMSCs and RAW264.7 macrophages, respectively, onto the 
CeONP-modified surface.
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2. Results
2.1. Materials Characterization
Figure 1a–d shows the surface morphologies of various sam-
ples. Acid cleaning left a relatively flat topography on the 
CeONP-0 surface (Figure 1a). Magnetron sputtering (2 min) 
and vacuum annealing then revealed tiny homogeneously dis-
tributed nanoparticles on the CeONP-1 surface (Figure 1b). 
Increasing the deposition time to 3 min (Figure 1c) and 5 min 
(Figure 1d) caused these nanoparticles to develop gradually 
into relatively larger ones. The X-ray diffractometry (XRD) 
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Figure 1. Surface morphologies of samples CeONP-0 a), CeONP-1 b), CeONP-2 c), and CeONP-3 d). XRD patterns e) and XPS full spectra f) of the 
samples. Development of Ce 3d XPS spectra f) and the fitted Ce 3d spectra of CeONP-1 h), CeONP-2 i), and CeONP-3 j), with the corresponding 
analysis results k) of valence concentration of Ce(IV) and Ce(III). UV–vis absorbance spectra l) of the samples and the corresponding conversion curves 
using the Kubelka–Munk function m). Fitted high resolution XPS spectra of Ti2p core levels for the samples CeONP-0 n), CeONP-1 o), CeONP-2 p), 
and CeONP-3 q).
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patterns (Figure 1e) and the diffraction peaks of the tita-
nium substrate revealed a diffraction peak for the CeO2 (111) 
facet.[21] In addition, a peak of TiO2 emerged due to the crys-
tallization of a natural oxide layer on the titanium surface.[30] 
Therefore, these nanoparticles had the characteristics of CeO2 
nanoparticles.
Figure 1f shows the surface X-ray photoelectron spectroscopy 
(XPS) survey spectra of various samples. The corresponding 
surface elemental compositions are listed in Table 1. Increases 
in the deposition time from 2 to 5 min increased the content 
of the Ce element on the surface from an initial 0 at% for 
CeONP-0, 3.57 at% for CeONP-1, and 5.82 at% for CeONP-2 
to 7.58 at% for CeONP-3. Accordingly, the content of the Ti ele-
ment on the surface decreased from 25.53 at% for CeONP-0, 
25.50 at% for CeONP-1, and 21.31 at% for CeONP-2 to 
17.13 at% for CeONP-3. Interestingly, the content of the surface 
O element dropped from 74.47 at% for CeONP-0 to 70.93 at% 
for CeONP-1, and then increased to 72.87 at% for CeONP-2 
and 75.29 at% for CeONP-3.
The high resolution XPS spectra of Ce 3d were acquired from 
the surfaces of various CeONP samples, as shown in Figure 1g; 
this consisted of two parts: (i) 916.7, 907.3, and 901.0 eV for 
Ce 3d3/2 and 898.3, 888.8, and 882.4 eV for Ce 3d5/2 of CeO2 
(solid line); (ii) 904.0 and 899.7 eV for Ce 3d3/2 and 885.8 and 
880.7 eV for Ce 3d5/2 of Ce2O3 (dashed line).[20] The evolution of 
the Ce 3d XPS spectra was analyzed by further fitting of these 
high resolution spectra, as shown in Figure 1h–j. A detailed 
description of the Ce 3d spectra fitting procedure was given pre-
viously.[31] Figure 1h–j shows qualitatively the relative changes 
in the Ce 3d XPS spectra for various CeONP samples. The cor-
responding quantitative results of the valence concentrations 
shown in Figure 1k confirm that, as deposition time increased, 
the concentrations of surface Ce4+ (CeO2) increased from 0% 
for CeONP-0, 31.5% for CeONP-1 and 55.1% for CeONP-2 to 
76.3% for CeONP-3. Accordingly, the concentrations of surface 
Ce3+ (Ce2O3) decreased from 68.5% for CeONP-1 to 23.7% for 
CeONP-3.
Figure 1i depicts the UV–vis absorption spectra of the var-
ious samples. A strong absorption at ≈400 nm for CeONP-0 
was ascribed to the absorption edge of TiO2. Interestingly, the 
increase in deposition time from 2 to 5 min shifted the absorp-
tion edge to a longer wavelength range. The diffuse reflectance 
spectra were converted into equivalent absorption coefficients 
using the Kubelka–Munk function:[32] α = (1 − R)2/2R, 
αhν = C1(hν – Eg)2, hν = 1240/λ, where α is the optical absorp-
tion coefficient near the absorption edge for the indirect inter-
band transition, R is the reflectance of the semiconductor, C1 is 
a constant for the indirect transition, hν is the photon energy, 
Eg is the indirect bandgap energy (eV), and λ is the wavelength 
(nm). Figure 1m depicts the (αhν)1/2 plot versus hν; here, the 
vertical segments of the spectra were extended to intersect 
with the hν axis to obtain the Eg for the CeONP samples. The 
narrowed bandgap agreed with the red shift of the absorption 
edge, which corresponded to the increase in nanoparticle size 
and surface Ce4+ content for the CeONP samples from 2 to 
5 min.[33] In addition, the high resolution XPS spectra of Ti2p 
core levels from the various samples were fitted in Figure 1n–q. 
The doublet peak at 458.8 eV and 464.4 eV belongs to the 
Ti2p3/2 and Ti2p1/2 in TiO2, respectively.[30] This indicates that 
the TiO2 remained on titanium substrate after depositing 
cerium oxides.
2.2. Cell Viability
Figure 2 shows the proliferation and viability of rat BMSCs 
after culturing on various samples for 1, 4, and 7 d. At day 1, 
no significant difference was noted among the groups. How-
ever, after 4 d of culture, obvious differences emerged between 
the CeONP samples and the control group. The CeONP sam-
ples significantly promoted cell proliferation on the surface in 
a manner dependent on the Ce4+/Ce3+ ratio (0.46 for CeONP-1, 
1.23 for CeONP-2, and 3.23 for CeONP-3). Furthermore, the 
increase in the surface Ce4+ content resulted in a better promo-
tion effect on cell proliferation for the CeONP-2 and CeONP-3 
samples than for the CeONP-1 samples (P < 0.05). At day 7, 
the cell growth on all samples maintained an upward trend, 
with an apparent difference between the testing groups and 
the control group. CeONP-3 induced the highest cell prolifera-
tion and viability. Thus, an increase in the surface Ce4+ con-
tent can promote the proliferation of rat BMSCs on CeONP 
samples.
Adv. Sci. 2018, 5, 1700678
Table 1. Elemental components of CeONP-0, CeONP-1, CeONP-2, and 
CeONP-3 analyzed by XPS. Analyzing area: 2.0 mm × 2.0 mm.
Sample Elemental concentration [at%]
Ce Ti O
CeONP-0 0 25.53 74.47
CeONP-1 3.57 25.50 70.93
CeONP-2 5.82 21.31 72.87
CeONP-3 7.58 17.13 75.29
Figure 2. CCK-8 assay results of proliferation and viability of rat BMSCs 
after 1, 4, and 7 d of culture on samples CeONP-0, CeONP-1, CeONP-2, 
and CeONP-3. Note: *P < 0.05, **P < 0.01, ***P < 0.001 versus CeONP-0; 
#P < 0.05, ##P < 0.01 versus CeONP-1; $$P < 0.01 versus CeONP-2; ns, 
not significant.
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2.3. In Vivo Osseointegration
2.3.1. Micro-CT Evaluation of Bone Formation
All the samples were implanted in rat femur bones for 8 weeks 
to enable the in vivo evaluation of osseointegration. Figure 3a 
shows the reconstructed micro-CT images along the central 
axis of the implants, with the implants marked in pink and the 
newly formed bones marked in grey. This figure shows that 
the bone volume is visually larger around the surface of the 
CeONP-3 implant than around the other implants. As shown in 
Figure 3d, the BV/TV of CeONP-3 was 14.1%, which was signif-
icantly higher than the 7.8% obtained with CeONP-0 (P < 0.05) 
and 2.1% with CeONP-1 (P < 0.01). CeONP-2 also had a better 
outcome of 10.8% compared with CeONP-1 (P < 0.01). A sim-
ilar trend was observed for Tb.Th (Figure 3e) and bone min-
eral density (BMD) (Figure 3f). Both CeONP-3 (0.46 mm−1) 
and CeONP-2 (0.44 mm−1) produced higher outcomes than 
CeONP-1 (0.14 mm−1, P < 0.01) for Tb.N (Figure 3g). For these 
parameters, worse outcomes were obtained with CeONP-1 than 
with CeONP-0 (P < 0.05). Consequently, the new bone forma-
tion around the implants displayed an obvious correlation with 
the surface Ce4+ content in the CeONPs.
2.3.2. Sequential Fluorescent Labeling
The process of new bone formation and mineralization 
around the implants was recorded using three types of fluo-
rochrome at different time points and the results are shown 
in Figure 3b. This figure shows that CeONP-3 and CeONP-2 
had better outcomes in terms of promoting new bone forma-
tion when compared with CeONP-0 and CeONP-1. The per-
centages of fluorochrome labeled area are shown in Figure 3h. 
At week 2, the percentage of Alizarin Red S labeled area (red) 
was significantly higher for CeONP-2 and CeONP-3 than for 
CeONP-0 and CeONP-1 (P < 0.01). CeONP-1 had a lower value 
than CeONP-0 (P < 0.05) and CeONP-3 had a better outcome 
than CeONP-2 (P < 0.05). At week 4 and week 6, the percent-
ages of tetracycline hydrochloride labeled area (yellow) and 
calcein labeled area (green) exhibited a similar tendency. There-
fore, these results confirmed that the increase in surface Ce4+ 
content in the CeONPs could promote new bone formation and 
mineralization at the bone-implant interface.
2.3.3. Histological Observation
The van Gieson’s picrofuchsin staining is a central his-
tological test for establishing whether implants are in 
direct contact with the surrounding bones. The histolog-
ical staining results for the sections in the present study 
are shown in Figure 3c. The corticocancellous site shows 
a close apposition of bone to implant for CeONP-3. The 
implant surface bonds tightly and directly with the newly 
formed bone, virtually without fibrous or connective 
tissue that would prevent its direct contact with new bone. 
Similarly, CeONP-2 also produces a good outcome regarding 
new bone apposition. By contrast, only a small amount of new 
bone appeared around the CeONP-1 implant within the cor-
ticocancellous bone, and an interspace was apparent between 
the newly formed bone and the implant surface. The percent-
ages of bone-implant contact (BIC) in the osseointegration 
region, observed at ×10 magnification, are given in Figure 3i. 
In agreement with the micro-CT results, significantly higher 
BIC percentages were obtained with CeONP-3 and CeONP-2 
than with CeONP-0 (P < 0.05) and CeONP-1 (P < 0.01). The 
BIC percentage was also lower for CeONP-1 than for CeONP-0 
(P < 0.05) and the BIC percentage was higher for CeONP-3 
than for CeONP-2 (P < 0.05). Therefore, an increase in the 
surface Ce4+ content in the CeONPs can promote new bone 
formation around the implant and enhance osseointegration.
2.3.4. Biomechanical Push-Out Test
The biomechanical push-out test was utilized to evaluate the 
quality of osseointegration of the implants. Figure 4 shows that, 
among the various groups, CeONP-3 had the largest failure 
load of 175.7 N whereas CeONP-1 had the lowest failure load 
of 80.6 N. Both CeONP-3 and CeONP-2 (164.7 N) had larger 
failure loads than CeONP-0 (135.9 N, P < 0.05) and CeONP-1 
(P < 0.01). The failure load was lower for CeONP-1 than for 
CeONP-0 (P < 0.01). Therefore, an increase in the surface Ce4+ 
content on CeONPs could enhance the osseointegration quality 
of the implant.
2.3.5. Scanning Electron Microscopy (SEM) Observation
The surface morphologies of the pushed-out implants were 
observed by SEM and the element distributions in the implants 
were mapped by energy dispersive X-ray spectroscopy (EDS) for 
further examination of the new bone formation on the surface 
of the implants in the bone marrow cavity. The SEM images in 
Figure 5 show the typical interface bonding status between the 
implants and new bone tissues. The CeONP-0, at low magnifi-
cation, shows some large blocks of new bone tissues remaining 
on the implant surface, indicating a strong interface bonding 
strength between the implant and new bone tissues. At high 
magnification, the implant showed a rough surface due to the 
adhesion of new bone tissues (Figure S1, Supporting Informa-
tion). This rough structure was more apparent at the higher 
magnification in Figure 5. By contrast, CeONP-1, shows a rela-
tively bare implant surface, indicating poor interface bonding 
strength between the implant and new bone tissues. At high 
magnification, the implant displayed a relatively smooth sur-
face morphology (Figure S1, Supporting Information) and 
this became more obvious at higher magnification, as shown 
in Figure 5. CeONP-2 and CeONP-3 show larger blocks of new 
bone tissues remaining on the implant surface, indicating a 
very strong interface bonding strength between the implant and 
new bone tissues. This was further supported by the rough mor-
phology seen under high magnification. Therefore, the SEM 
results were agreed well with the push-out results in Figure 4.
EDS mapping showed that the newly formed bone tissues 
were characterized by intense distribution maps of calcium 
(green) and phosphorus (gray). Figure 5 shows the mapping 
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results that were very consistent with the SEM results. The 
weak distribution maps for titanium (blue), as a counterpart, 
can be used to estimate the coverage and thickness of new bone 
tissues on the implants. Therefore, the SEM and EDS results 
agreed well with the results for new bone formation obtained 
with the other methods.
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Figure 3. Micro-CT images of reconstructed 3D models of surrounding bones in transverse and longitudinal views, with or without implants a), accom-
panied by the corresponding quantitative analysis results of BV/TV d), Tb.Th e), BMD f), and Tb.N g). Sequential fluorescent labeling observation b), 
accompanied by the corresponding analysis results h) of the area of bone stained with the three fluorochromes. (Note: Red labeling, Alizarin Red S, 
week 2; yellow labeling, tetracycline, week 4; green labeling, calcein, week 6; *P < 0.05, **P < 0.01 versus CeONP-0; ##P < 0.01 versus CeONP-1; $P < 0.05 
versus CeONP-2.) Histological observation c) of the CeONP-0, CeONP-1, CeONP-2, and CeONP-3 sections stained with Van Gieson’s picrofuchsin, 
accompanied by the corresponding analysis results i) of bone-implant contact from the histomorphometric measurement at ×10 magnification. (Note: 
*P < 0.05 versus CeONP-0; ##P < 0.01 versus CeONP-1; $P < 0.05 versus CeONP-2.)
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2.4. Osteogenic Mechanism
2.4.1. In Vitro Osteogenic Regulation
Further understanding of the outcome of new bone forma-
tion and mineralization and their regulation by CeONPs was 
obtained using quantitative real-time polymerase chain reaction 
(PCR) assays. The key osteogenic-related markers, including 
alkaline phosphate (ALP) (Figure 6a,f), collagen type I (Col-I) 
(Figure 6b,g), osteocalcin (OCN) (Figure 6c,h), osteopontin 
(OPN) (Figure 6d,i), and runt-related transcription factor 2 
(Runx-2) (Figure 6e,j), were investigated to determine the 
influence of the surface Ce4+ content of the CeONPs on the 
osteogenic differentiation of rat BMSCs at the molecular level. 
The cells were cultured on CeONPs for 1 and 7 d. At day 1 
(Figure 6a–e), a significant promoting effect was observed for 
the expression of the ALP, Col-I, OCN, OPN, and Runx-2 genes 
in response to CeONP-3 and CeONP-2 but not in response 
to CeONP-1 and CeONO-0 (P < 0.05). CeONP-1 induced an 
obvious down-regulation of these osteogenesis genes when 
compared with CeONP-0 (P < 0.05). At day 7 (Figure 6f–j), the 
difference in the expression of these genes between CeONP-3 
and other groups became more significant (P < 0.01).
ALP is an early marker of BMMSC differentiation, so its 
measurement at day 7 was used to evaluate the osteogenic 
differentiation potential of the CeONP samples. As shown in 
Figure 6k, significantly higher ALP activity was observed for 
both CeONP-3 and CeONP-2 than for CeONP-1 (P < 0.01) and 
CeONP-0 (P < 0.05). ALP activity was also lower for CeONP-1 
than for CeONP-0 (P < 0.05).
Similarly, Alizarin Red S (ARS) was determined to eval-
uate calcium nodule formation in the samples. As shown in 
Figure 6l, ARS activity was apparently higher for CeONP-3 and 
CeONP-2 than for CeONP-0 and CeONP-1 (P < 0.05).
OPN expression in the rat BMSCs was detected by an 
immunofluorescence assay with DyLight 488. As shown in 
Figure 6m, CeONP-3 induced the strongest immunofluores-
cence labeling of OPN expression, whereas CeONP-1 produced 
the weakest green fluorescence. More BMSCs that expressed 
the relevant specific protein were detected for CeONP-3 than 
for the other groups. Therefore, an increase in the surface Ce4+ 
content in the CeONPs can promote in vitro osteogenic differ-
entiation of rat BMSCs, thereby accounting, at least in part, for 
the enhanced new bone formation around the implant and for 
osseointegration.
2.4.2. Macrophage Response
Figure 7 shows the analysis results for flow cytometry assay 
and ELISA of RAW264.7 macrophages. The percentage of M1 
cells that expressed the surface marker CCR7 showed the fol-
lowing trend (Figure 7a–d): CeONP-1 (87.64%) > CeONP-0 
(66.52%) > CeONP-2 (58.64%) > CeONP-3 (46.46%). By 
contrast, the percentage of M2 cells expressing the surface 
marker CD206 showed the following trend (Figure 7e–h): 
CeONP-1 (30.18%) < CeONP-0 (45.40%) < CeONP-2 (51.80%) < 
CeONP-3 (69.70%). The production of the pro-inflammatory 
cytokine tumor necrosis factor-α (TNF-α) in the supernatants 
recovered from various samples (Figure 7i) indicated a sig-
nificantly higher TNF-α concentration for CeONP-1 than for 
CeONP-3 (P < 0.01) and CeONP-2 (P < 0.05) at day 1.The TNF-
α concentration was also lower in response to CeONP-3 than in 
response to CeONP-0 (P < 0.05). The same trend was observed 
after 4 d of culture. A statistically significant difference was 
observed between the responses to CeONP-3 and CeONP-2 
(P < 0.05), and the concentration was higher for CeONP-1 than 
for CeONP-0 (P < 0.05).
Production of the anti-inflammatory cytokine interleukin-10 
(IL-10) in the medium retrieved from various samples 
(Figure 7j) indicated higher expression of IL-10 in response to 
CeONP-3 and CeONP-2 when compared with CeONP-0 and 
CeONP-1, and this difference was statistically significant at both 
day 1 (P < 0.05) and day 4 (P < 0.01). At day 1, a higher IL-10 
level was induced in response to CeONP-3 than to CeONP-2 
(P < 0.05), and at day 4, a lower IL-10 level was obtained with 
CeONP-1 than with CeONP-0 (P < 0.05). Therefore, an increase 
in surface Ce4+ content in the CeONPs suppresses the produc-
tion of a proinflammatory cytokine but induces higher levels 
of an antiinflammatory cytokine; these are both characteristic 
responses of M2 macrophages.
3. Discussion
During magnetron sputtering using highly pure CeO2 target 
(Scheme 1a), subtle fluctuations in deposition may cause a 
dynamic departure from stoichiometry, which then induces a 
localized cerium or oxygen excess and creates oxygen or cerium 
vacancy point defects.[34] In the case of localized oxygen excess, 
the charge neutrality demands the creation of cerium vacan-
cies (defect reaction in Kröger–Vink notation: O ↔ VCe4′ + 
4h• + OO×). The holes (h•) are trapped at the nearest-neighbor 
Ce4+ sites to create Ce5+. However, this happens only with dif-
ficulty since the highest oxidation state is 4+ for cerium. In the 
case of localized cerium excess, charge neutrality demands the 
creation of oxygen vacancies (Kröger–Vink notation: OO× ↔ 
VO•• + 2e′ + 1/2O2). The electrostatic attractive forces can trap 
Adv. Sci. 2018, 5, 1700678
Figure 4. Results of biomechanical testing. Note: *P < 0.05, **P < 0.01 
versus CeONP-0; ##P < 0.01 versus CeONP-1; $P < 0.05 versus CeONP-2.
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the electrons (e′) at the Ce4+ sites to create Ce3+. As a result, 
the heterogeneous deposition of cerium and oxygen atoms can 
create an oxygen-deficient nonstoichiometric phase (CeO2−x) 
with oxygen vacancies.
The relative content of Ce4+ or Ce3+ is a function of the par-
ticle size of CeONPs. In general, the fraction of Ce3+ in parti-
cles increases as the particle size decreases; i.e., the Ce4+/Ce3+ 
ratio increases with increases in the particle size.[29] Here, by 
tuning the deposition time of the magnetron sputtering, the 
particle size was controlled and a high Ce4+/Ce3+ ratio was 
obtained for the CeONPs (Scheme 1a). XPS analysis revealed 
the changes in the surface element compositions of the various 
samples, as shown in Table 1. The development of surface 
oxygen content serves as an indicator of the change in the sur-
face oxygen vacancy concentration in the various samples. The 
apparent drop in the surface oxygen content from 74.47 at% 
for CeONP-0 to 70.93 at% for CeONP-1 indicated the presence 
of oxygen vacancies on the surface. Subsequent increases in 
the surface oxygen content revealed a decrease in the number 
of oxygen vacancies on the surface, which corresponded to 
the increase in surface Ce4+ content and the decrease in sur-
face Ce3+ content in the CeONPs. The sampling depth of XPS 
analysis is ≈10 nm,[35] so the measured Ce4+ and Ce3+ con-
tents were derived from the outermost surface of the CeONPs. 
With regard to the bonding between CeNPs and titanium sub-
strate, only the diffraction peaks of CeO2, TiO2, and Ti phases 
are detected in XRD (Figure 1e). Also, all the XPS spectra of 
Ce3d core levels in Figure 1g–j belong to the cerium oxide, i.e., 
CeO2 or Ce2O3 and all the XPS spectra of Ti2p core levels in 
Figure 1n–q are labeled to TiO2. Hence, no interfacial reaction 
is found between cerium oxide and titanium oxide on the tita-
nium substrate.[36] Therefore, we believe that the cerium oxides 
are physically bonded to the titanium surface during magne-
tron sputtering.
Adv. Sci. 2018, 5, 1700678
Figure 5. Surface morphologies of the implants of various samples, accompanied by the corresponding EDS elemental mapping and distribution of 
C, O, P, Ca, Ti, and Ce.
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The Ce4+ state is the preferentially formed (CeO2) oxide of 
cerium. Nevertheless, intrinsic defects are usually present, so 
that cerium will be present, in part, in the Ce3+ state (Ce2O3) 
containing oxygen vacancies.[37] The relative contents of Ce3+ 
and Ce4+ are a function of the particle size of the CeONPs,[15,29] 
such that the proportion of Ce3+ in the particles increases with 
decreasing particle size. The particle size of CeONPs can be 
regulated by magnetron sputtering and vacuum annealing, and 
the vacuum annealing can cause the deposited cerium oxide 
to grow into nanoparticles via Ostwald ripening. An increase 
in deposition time can further contribute to an increase in the 
particle size of the CeONPs.[38] The relative contents of surface 
Ce3+ and Ce4+ in the CeONPs were manipulated in this way in 
the present study, as shown in Figure 1k. The calculated sur-
face Ce4+/Ce3+ ratios for the CeONPs were 0.46, 1.23, and 3.23 
for CeONP-1, CeONP-2, and CeONP-3, respectively. Therefore, 
the prepared CeONPs were in a mixed valence state with an 
increasing surface Ce4+/Ce3+ ratio. As shown in Figure 2, an 
increase in the surface Ce4+/Ce3+ ratio can promote the prolif-
eration of rat BMSCs on CeONPs. This agrees with previous 
work showing that the nano-CeO2 region on a polymer scaffold 
promoted cell proliferation, while the nano-Ce2O3 region inhib-
ited cell proliferation.[20]
Figure 2 shows that the prepared CeONPs samples had 
favorable cytocompatibility. The in vivo animal test performed 
to investigate the influence of surface Ce4+/Ce3+ ratios on bone 
formation and mineralization around the CeONP-immobilized 
implants confirmed that the extent of new bone tissue forma-
tion and mineralization depended on the surface Ce4+/Ce3+ 
ratio of the CeONPs (Scheme 1a).
The micro-CT, sequential fluorescent labeling, and histo-
logical analysis results presented in Figure 3 further confirm 
that an increase in the surface Ce4+/Ce3+ ratio can promote new 
bone formation and mineralization around a CeONP-immobi-
lized implant. The better outcome for the biomechanical push-
out test, as shown in Figure 4, also demonstrates the increasing 
osseointegration quality of the implant with the increasing sur-
face Ce4+/Ce3+ ratio. These results were further supported by 
the SEM morphology observations and EDS element mapping 
of the newly formed bone tissues around the CeONPs-immobi-
lized implants, as shown in Figure 5 and Figure S1 (Supporting 
Information). The mechanism by which the Ce4+/Ce3+ ratio on 
the CeONP surface modulates new bone formation and min-
eralization was investigated by analyzing the expression levels 
of the osteogenesis-related genes, ALP, Col-I, OCN, OPN, and 
Runx-2, by quantitative real-time PCR in in vitro cultured rat 
BMSCs treated with various CeONP samples. The expres-
sion of these markers, as shown in Figure 6a–j, indicated an 
apparent relationship between the osteogenic differentiation of 
rat BMSCs and the surface Ce4+/Ce3+ ratio of the CeONPs.
Adv. Sci. 2018, 5, 1700678
Figure 6. Expression levels of osteogenic-related genes ALP a,f), Col-I b,g), OCN c,h), OPN d,i), and Runx-2 e,j) by real time PCR after culturing rat 
BMSCs on various samples for 1 and 7 d. ALP activity of rat BMSCs after 7 d of culture on various samples k). ARS activity of rat BMSCs after 14 d 
of culture on various samples l). Detection of OPN expression after culturing rat BMSCs on the samples for 7 d by immunofluorescence assay m). 
Note: *P < 0.05, **P < 0.01, ***P < 0.001 versus CeONP-0; #P < 0.05, ##P < 0.01, ###P < 0.001 versus CeONP-1; $P < 0.05, $$P < 0.01, $$$P < 0.001 
versus CeONP-2.
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An increase in the surface Ce4+/Ce3+ ratio promoted the 
in vitro osteogenic differentiation of rat BMSCs cultured on 
CeONPs. This response was also evident at the protein level, 
as shown in Figure 6k–m. SOD is an enzyme that catalyzes the 
disproportionation of superoxide, the most common free rad-
ical in body, into H2O2 and O2.[23b] The Ce4+/Ce3+ valence switch 
capability can endow CeONPs with SOD mimetic activity. 
The CeONPs with lower Ce4+/Ce3+ ratio have a higher SOD 
mimetic activity, and the superoxide dismutation by CeONPs is 
expressed as[24]
+ + → + + → +• − + + + • − + +O Ce 2H H O Ce ; O Ce O Ce2
3
2 2
4
2
4
2
3
 (1)
Catalase is a protective enzyme found within almost all 
living organisms exposed to oxygen. This enzyme catalyzes the 
degradation of H2O2, a powerful and potentially harmful oxi-
dizing agent, into H2O and O2.[39] CeONPs can possess cata-
lase mimetic activity that appears in a redox-state-dependent 
manner, and a higher Ce4+/Ce3+ ratio gives a higher catalase 
mimetic activity.[25]
Interestingly, the SOD mimetic activity and catalase mimetic 
activity of CeONPs are the opposite of that expected based 
on the Ce4+/Ce3+ ratio (Scheme 1b). CeONPs showing SOD 
mimetic activity will generate H2O2. Both in vitro and in vivo, 
excess H2O2 is believed to be more toxic than superoxide 
because it is the substrate for the Fenton reaction that creates 
the hydroxyl radical (•OH), the most destructive of the ROS.[40] 
Fortunately, CeONPs have both SOD and catalase mimetic 
activities, so the H2O2 created during the SOD mimetic process 
can enter into the catalase mimetic dismutation cycle and be 
decomposed into innocuous H2O and O2; these reactions make 
CeONPs an excellent antioxidant.[21,26] Nevertheless, the antioxi-
dative function of the CeONPs is only effective when the two 
enzyme mimetic activities are coordinated; in other words, the 
H2O2 decomposition rate should be equal to or higher than the 
production rate.
The SOD mimetic and catalase mimetic activities of the 
CeONPs should have a close relationship with the osteogenic 
differentiation of rat BMSCs, since these enzyme mimetic 
activities can regulate the production of ROS (Scheme 1c). 
The overproduction of ROS will decrease the osteogenesis of 
stem cells, but exogenous antioxidant treatment will promote 
this osteogenesis.[41] This dichotomy may account for the pro-
moting effect observed for an increase in the surface Ce4+/Ce3+ 
ratio with respect to the in vitro osteogenic differentiation of 
rat BMSCs cultured on CeONPs. A recent study using cerium 
oxide nanoparticles for functional recovery of spinal cord injury 
(SCI) indicated that the nanoparticles had a higher +4 oxidation 
status than +3 (Ce4+/Ce3+ = 2.9) and these CeONPs possibly car-
ried out an effective consumption of ROS to give rise to SCI 
recovery at the cost of changing their status primarily from Ce4+ 
to Ce3+.[19]
The host immune response is an essential component 
of the biomaterial-mediated osteogenic effect.[1b] Therefore, 
murine RAW264.7 macrophages were cocultured with CeONP 
samples to obtain a further understanding of the relationship 
Adv. Sci. 2018, 5, 1700678
Figure 7. Expression of cell surface markers on RAW264.7 macrophages determined by flow cytometry, showing the percentages of M1 phenotype 
(CCR7, a–d) and M2 phenotype (CD206, e–h). Production of cytokines TNF-α i) and IL-10 j) secreted by RAW264.7 macrophages cultured on various 
samples determined by ELISA. Note: *P < 0.05, **P < 0.01 versus CeONP-0; #P < 0.05, ##P < 0.01, ###P < 0.001 versus CeONP-1; $P < 0.05 versus 
CeONP-2.
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between the surface Ce4+/Ce3+ ratio of the CeONPs and new 
bone formation and mineralization. As shown in Figure 7, 
an increase in the surface Ce4+/Ce3+ ratio of the CeONPs pro-
moted macro phage polarization to the M2 phenotype and an 
increase in the production of the anti-inflammatory cytokine 
IL-10. Similarly, a decrease in the surface Ce4+/Ce3+ ratio pro-
moted macrophage polarization to the M1 phenotype and 
increased the production of the proinflammatory cytokine 
TNF-α. Taken together, these findings indicate that manipula-
tion of the surface Ce4+/Ce3+ ratio of the CeONPs can modu-
late the balance of anti-inflammatory and proinflammatory 
cytokines in macrophages and create an anti-inflammatory 
microenvironment (Scheme 1c).
Interestingly, previous work that investigated the capa-
bility of CeONPs to scavenge ROS and inhibit inflammatory 
mediator production in murine J774A.1 macrophages indi-
cated that oxidative stress and proinflammatory iNOS protein 
expression were abated by CeONP stimulation.[26] More impor-
tantly, recent work has shown that the prohealing M2-polar-
ized macrophage phenotype can elicit positive outcomes, 
both in vitro and in vivo, on osteogenesis, angiogenesis, and 
osseointegration.[8a,10] The CeONPs appear to show a valence-
dependent modulatory effect on macrophage polarization 
and cytokine production. In this context, in the present study, 
CeONP-1 had a negative effect on the balance between anti-
inflammatory and proinflammatory macrophage polarization 
and cytokine secretion, and its outcome was poorer even than 
that of CeONP-0.
The long-term survival and integration of biomaterials 
are largely determined by activation of the host immune 
system.[1b,42] Once a biomaterial is implanted into the host 
body, a sequence of immune responses and healing processes 
will occur in the surrounding tissues.[1b,42a] Macrophages play a 
vanguard role in the recognition of and adhesion to the foreign 
biomaterial.[42b,43] The close relationship between the immune 
and skeletal systems means that activated macrophages con-
tribute to both the success and the failure of transplantation of 
a foreign biomaterial. The macrophages exert this dichotomous 
effect by secreting cytokines that modulate either osteogenesis 
or inflammation, thereby promoting or inhibiting new bone 
formation.[42b,44]
A favorable macrophage polarization can create an osteo-
genic microenvironment that improves osteogenesis, whereas 
an unfavorable macrophage polarization may exacerbate 
Adv. Sci. 2018, 5, 1700678
Scheme 1. Schematic illustration of CeONPs immobilization on titanium implant biomaterials for bone tissue engineering and regenerative medicine: 
a) a layer of CeONPs surface fabricated on titanium surface by using magnetron sputtering is able to induce osteogenic differentiation of rat BMSCs 
and M2 phenotype polarization of macrophages, thereby resulting to the boost of new bone regeneration in vivo; b) the interactions of CeONPs with 
the superoxide anion radicals (•O2−) produced by mitochondria, including SOD mimetic and catalase mimetic activities; c) the correlations of valence 
state of CeONPs (Ce4+/Ce3+ molar ratio) layer with the cell fates of BMSCs and macrophages on osteogenesis.
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inflammation and destroy the tissue–biomaterial integra-
tion.[12,45] In general, the M2 macrophage phenotype accounts 
for antiinflammation and tissue regeneration, whereas the 
M1 macrophage phenotype is proinflammatory and causes 
tissue destruction. The results presented here indicate that an 
increase in the surface Ce4+/Ce3+ ratio of the CeONPs can pro-
mote the polarization of the healing-associated M2 macrophage 
phenotype and increase the secretion of antiinflammatory 
cytokine IL-10. The antiinflammatory cytokines secreted by M2 
macrophages can resolve inflammation and promote wound 
healing. IL-10 can inhibit pro-inflammatory cytokine secretion 
and activity and the secretion of granulocyte-macrophage colony 
stimulating factor and nitric oxide (NO) in macrophages.[46] By 
contrast, the secretion of pro-inflammatory cytokines by M1 
lead to delayed bone healing and pathogenic bone loss.[42b,43] 
As a result, the inhibition of TNF-α secretion by an increased 
surface Ce4+/Ce3+ ratio would benefit new bone formation and 
wound healing around a CeONP implant.
In summary, the mechanism of surface Ce4+/Ce3+ ratio of 
CeONPs on titanium substrate to induce bone-material integra-
tion is illustrated by a schematic diagram (Scheme 1). Manip-
ulating the surface Ce4+/Ce3+ ratio of CeONPs can modulate 
macrophage polarization and cytokine secretion, and facili-
tate appropriate immune reactions that balance antiinflam-
mation and pro-inflammation, which lead to the satisfactory 
outcomes of new bone formation and bone–biomaterial inte-
gration. The introduction of a biomaterial into the body initi-
ates an inflammatory cascade due to cell and tissue damage, 
and this cascade persists for roughly 4 d.[13] This early inflam-
matory response is highly beneficial to the host, it must subse-
quently be terminated to avoid tissue damage and to promote 
tissue regeneration.[14] Any unrestrained pro-inflammatory M1 
macrophage polarization induced by biomaterials will therefore 
impair new bone formation and osseointegration[8b] and pre-
vent wound healing.[47] Therefore, CeONPs biomaterials must 
have appropriate modulatory effects on the balance between 
antiinflammation and pro-inflammation immune reactions in 
order to elicit the desired outcomes of bone regeneration and 
osseointegration.
4. Conclusion
A customized magnetron sputtering and vacuum annealing 
protocol is applied to establish a layer of cerium oxide nano-
particles (CeONPs) with different surface Ce4+/Ce3+ ratios (0.46, 
1.23, 3.23) on titanium surface serving as an experimental plat-
form to examine the regulatory effect of CeONPs on cell fate 
and bone formation. The CeONPs with a mixed valence state 
and a high surface Ce4+/Ce3+ ratio exhibit better cytocompat-
ibility with rat BMSCs. Moreover, when implanted into the 
rat femurs, it is found that new bone formation and bone–
implant integration is highly correlated with the surface Ce4+/
Ce3+ molar ratio. The in vivo outcomes are supported by the 
in vitro studies of rat BMSCs cultured with CeONP samples. 
The results confirmed that the osteogenic related gene and 
protein expressions were significantly upregulated, when the 
cells cultured with the titanium surface with higher Ce4+/Ce3+ 
ratio. Furthermore, while culturing with RAW264.7 murine 
macrophages, the polarization of macrophages to the M2 phe-
notype is highly expressed on the surface with increased Ce4+/
Ce3+ ratio in which the gain of prohealing M2 percentage can 
increase antiinflammatory cytokine production. Thus, the 
mixed valence state of CeONPs has the potential to induce bone 
regeneration without the need for any exogenous osteogenic 
inducer. These results suggest that manipulation of the valence 
state of CeONPs can exert a desirable modulatory effect on 
stem cell and macrophage fates to elicit the beneficial outcomes 
of CeONPs on new bone formation and osseointegration.
5. Experimental Section
Sample Fabrication: The cerium oxide nanoparticles were deposited 
with a magnetron sputtering apparatus (ULVAC Corp., Model ACS-
4000-C4) using a high purity CeO2 target at a radio frequency power 
of 80 W. Acid cleaned metal titanium plates or rods (99.95 wt%) 
were chosen as the deposition substrate. In brief, titanium plates 
(10 mm × 10 mm × 1 mm, 20 mm × 20 mm × 1 mm, and 20 mm × 
10 mm × 1 mm) and rods (Ø 2 mm × 7 mm) were first pickled in oxalic 
acid solution (5 wt%) at 100 °C for 2 h to clean the surfaces, followed by 
thorough washing with ethanol and fresh water. Before CeO2 deposition, 
the deposition chamber was first pumped down to ≈10−4 Pa and then 
pure Ar gas (99.999%) was introduced at 50 sccm. During deposition, 
the substrate was rotated along the vertical axis at a speed of 10 rpm to 
improve homogeneity. The samples were fabricated by depositing CeO2 
on the substrate target by sputtering for 2, 3, and 5 min. The samples 
were then vacuum annealed at 450 °C. For simplicity, the obtained 
cerium oxide samples were designated as “CeONP-1,” “CeONP-2,” 
and “CeONP-3,” respectively. The acid-cleaned and vacuum-annealed 
metal titanium acted as the control material and was designated as 
“CeONP-0.”
Sample Characterization: The surface morphologies were studied 
using field-emission SEM (LEO 1530, Germany); the instrument was 
capable of EDS. The crystallinity was studied by XRD (Rigaku Ultima IV, 
Japan) using a Cu Kα (λ = 1.541 Å) source in the range of 2θ = 20°–90° 
with a glancing angle of 1°. Phase identification was done with the help 
of the JCPDS database. The surface chemical composition and chemical 
state were determined by XPS (Physical Electronics PHI 5802) using 
an Al Kα source (1486.6 eV). The optical diffuse reflectance spectra 
were recorded on UV–vis–NIR spectrophotometer (Model UV-4100, 
Hitachi Corp.).
Cytocompatibility Evaluation: Cell Culture: The rat BMSCs were 
purchased from the Cell Bank of Chinese Academy of Sciences and 
cultured in Dulbecco’s modified Eagle’s medium (DMEM; HyClone) 
supplemented with 10% fetal bovine serum (FBS; Gibco) and a 1% 
antibiotic/antimyotic solution. The BMSCs were cultured at 37 °C 
in a humidified 5% CO2 incubator and passaged every 3 d at ≈80% 
confluence. Only the confluent BMSCs at passages 3–5 were harvested 
for further study.
Cell Proliferation Assay: The proliferation activities of rat BMSCs on 
various samples were determined using the CCK8 assay. Initially, 5 × 104 
cells were seeded into the wells of a 24 well plate. After 1, 4, and 7 d of 
culture, CCK8 solution, at a volume of ≈10% of the culture medium, and 
incubated for 1 h at 37 °C to react with cells. The medium was refreshed 
and the absorbance was measured at 450 nm on an ELX ultra microplate 
reader (BioTek, Winooski, VT). Four samples were used for each group 
and all tests were repeated three times.
In Vivo Animal Experiment: Surgical Procedures: All experimental 
protocols concerning animals were approved by the Animal Committee 
of the Ninth People’s Hospital Affiliated to Shanghai Jiao Tong 
University School of Medicine. A rat femoral model was used in this 
study. Thirty-two six-month-old female Sprague–Dawley (SD) rats 
were randomly divided into the following four groups (8 rats/group): 
(i) CeONP-0 group (n = 8), (ii) CeONP-1 group (n = 8), (iii) CeONP-2 
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group (n = 8), and (iv) CeONP-3 group (n = 8). Surgical procedures were 
performed under sterile conditions, as described previously.[48] Briefly, 
the rats were first anesthetized by intraperitoneal injection of ketamine. 
After the hind limb was shaved, an ≈0 mm longitudinal incision 
was made across the knee joint along the lateral side of the extensor 
mechanism. A pilot hole was drilled along the long axis of the femur 
through the intercondylar notch and the distal femoral metaphysis, and 
the implants were inserted. After surgery, all rats received antibiotic and 
analgesic injections intramuscularly for three postoperative days.
Sequential Fluorescent Labeling: A polychrome sequential fluorescent 
labeling method was used to assess the process of new bone formation 
and mineralization.[48] At 2, 4, and 6 weeks after surgery, different 
fluorochromes were intraperitoneally administered at a sequence of 
30 mg kg−1 Alizarin Red S (Sigma), 25 mg kg−1 tetracycline hydrochloride 
(Sigma), and 20 mg kg−1 calcein (Sigma), respectively.
Sample Preparation: All rats were sacrificed at weeks 8 after surgery. 
Left femurs, with four groups of implants, were harvested and trimmed 
into smaller samples for subsequent use (i.e., 8 left femurs/group, 
n = 8).
Micro-CT Evaluation: The presence of newly formed bone around the 
inserted implants was determined using micro-CT (GE explore Locus SP 
Micro-CT, USA). The scanning parameters were set at 80 kV and 80 µA, 
with 3000 ms of exposure time and 15 µm of resolution. After scanning, 
3D images were reconstructed using NRecon software (SkyScan, USA) 
and the CTvol program (SkyScan). The BMD, bone volume fraction 
(bone volume/total volume, BV/TV), trabecular number (Tb.N), and 
trabecular thickness (Tb.Th) were analyzed for newly grown bone tissues 
using DataViewer software (SkyScan) and the CTAn program (SkyScan).
Histomorphometric and Histological Observation: After micro-CT 
scanning, the femur samples of each group were dehydrated in a 
graded series of alcohol solutions from 75% (v/v) to 100% (v/v), and 
embedded in polymethylmethacrylate. The samples were cut into 
150 µm thick sections using a Leica SP1600 saw microtome (Leica, 
Nusseloch, Germany). These sections were then ground and polished 
to a final thickness of ≈40 µm for fluorescence labeling observation 
with a confocal laser scanning microscope (CLSM; Leica TCS Sp2 
AOBS, Germany). Excitation/emission wavelengths for the chelating 
fluorochromes were 405/580 nm for tetracycline hydrochloride (yellow), 
543/617 nm for Alizarin Red S (red), and 488/517 nm for calcein (green). 
The percentage of each single fluorochrome staining area, indicating the 
new bone formation and mineralization at 2, 4, and 6 weeks after surgery, 
was calculated with Image-Pro Plus software (Media Cybernetics, Silver 
Spring, MD, USA). After fluorescence analysis, these sections were 
stained with Van Gieson’s picrofuchsin for histological observation and 
histomorphometric analysis.
Push-Out Test: This biomechanical test was conducted on a universal 
material testing system (Instron, High Wycombe, UK). A special custom-
designed holder was used for the test samples to ensure the test force 
was along the long axis of the implants, which were trimmed to fit into 
the holder. All tests were conducted at a loading rate of 5 mm min−1. The 
load–displacement curves were recorded during the pushing period. The 
failure load was defined as the peak load value of the load-displacement 
curve.
SEM Observation: Rat femurs with four groups of implants were 
randomly selected for SEM observation. Briefly, after the push out 
tests, the implants were fixed with 2.5% glutaraldehyde solution at 4 °C 
overnight, and then sequentially dehydrated in a graded series of ethanol 
solutions (30, 50, 75, 90, 95, and 100%, v/v). Prior to SEM observation, 
the samples were sputter coated with platinum. The corresponding 
elemental distribution on the implant surfaces was detected by EDS 
mapping.
In Vitro Osteogenic Evaluation: ALP Activity Assay: Rat BMSCs were 
seeded in 24 well plates at density of 5 × 104 cells per well. After 7 d 
of culture, the cells were stained using an ALP kit (Beyotime, China), 
according to the manufacturer’s instructions. For ALP quantitative 
assay, the cells were incubated with p-nitrophenyl phosphate (Sigma) at 
37 °C for 30 min. ALP activities were determined by recording optical 
density (OD) values at 405 nm. Total protein contents were calculated 
using a Bio-Rad protein assay kit (Bio-Rad, USA) and normalized with 
a range of bovine serum albumin (BSA) (Sigma) standards at 630 nm. 
ALP activities were expressed as OD values at 405 nm per mg of 
total protein.
Calcium Deposition Assay: Calcium deposition was evaluated at 14 d 
by ARS staining. Cells were washed twice with phosphate buffered saline 
(PBS) and fixed in 95% alcohol for 15 min. The cells were stained with 
0.1% ARS solution and then desorbed with 10% cetylpyridinium chloride 
(Sigma) for quantification. The OD values for absorbances of the eluent 
were recorded at 590 nm. Total protein contents were measured using 
the Bio-Rad protein assay kit at 630 nm. Results were normalized and 
expressed as OD values per mg of total protein.
Real-Time PCR Analysis: Total cellular RNA was extracted at 1 and 
7 d with TRIzol reagent (Invitrogen) according to the manufacturer’s 
instruction. Two micrograms of total RNA was used as the template for 
reverse transcription with Prime-Script RT reagent kit (Takara Bio, Shiga, 
Japan). The expression of osteogenic genes, including Runx-2, OCN, 
OPN, Col-I, and ALP, was determined using a real-time PCR system 
(Bio-Rad) with SYBR GREEN PCR Master Mix. The primer sequences 
for these genes are listed in Table S1 (Supporting Information). Gene-
specific primers were synthesized commercially (Shengong Co., Ltd. 
Shanghai, China). The housekeeping gene, glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), was used for normalization. CeONP-0 acted 
as the control for relative gene expression. All assays were carried out 
in triplicate.
Immunofluorescence Observation: OPN expression was detected by 
seeding rat BMSCs on samples at a density of 5 × 105 cells per well and 
cultured for 7 d. The samples were then washed with PBS three times 
and fixed in 4% paraformaldehyde at 4 °C for 30 min. Subsequently, the 
cells were permeabilized with 0.1% Triton X-100 for 30 min and blocked 
in 10% goat serum for 1 h at room temperature. A specific primary 
antibody targeting rat OPN (Abcam) was added at 1:100 dilution for 
overnight coincubation at 4 °C. DyLight 488-conjugated anti-mouse IgG 
antibody (Boster, China) at a 1:100 dilution was added and incubated 
for 30 min at room temperature in the dark. These samples were 
observed by CLSM after the cell nuclei were contrast-labeled with DAPI 
(Sigma, USA).
Macrophage Study: Cell Culture: The RAW264.7 murine-derived 
macrophage cell line was purchased from the Cell Bank of Chinese 
Academy of Sciences and maintained in DMEM supplemented with 
10% FBS and 1% penicillin/streptomycin at 37 °C in humidified 5% CO2 
incubator. The culture medium was exchanged every 48 h. The growing 
cells were passaged at ≈80% confluence by scraping, and only passages 
3–5 were used in the study.
Flow Cytometry Analysis: Flow cytometry was used for quantitative 
analysis of the expression of CCR7 (M1 marker) and CD206 (M2 
marker). In total, 5 × 105 cells were seeded onto various samples 
(20 mm × 20 mm × 1 mm). After culturing for 4 d, the cells were trypsinized 
and scraped from the sample surfaces, centrifuged, and resuspended in 
1% BSA for 30 min at ambient temperature to block nonspecific antigens. 
The cells were then incubated with fluorescein isothiocyanate (FITC)-
conjugated anti-mouse F4/80, allophycocyanin (APC)-conjugated CCR7, 
and phycoerythrin (PE)-conjugated CD206 for 1 h in the dark at ambient 
temperature in a final volume of 100 µL. FITC-conjugated rat IgG2a,κ, 
APC-conjugated rat IgG2a,κ, and PE-conjugated rat IgG2a,κ acted as 
isotype controls. All flow cytometry antibodies were purchased from 
eBioscience. After washing twice in 1% BSA, the cells were resuspended 
in 1% BSA and analyzed with a Guava flow cytometer (Millipore, USA); 
5 × 103 cells were analyzed in each test. Data were analyzed using 
guavaSoft 3.1.1 software.
Cytokine Measurement: The production of relevant cytokines was 
measured using enzyme-linked immunosorbent assays (ELISAs). After 
1 and 4 d of culture, the culture medium was aspirated and centrifuged, 
and the supernatant was utilized for analyses. The concentrations of 
TNF-α and IL-10 were measured with ELISA kits (Anogen, Canada), 
following the manufacturer’s instructions.
Statistical Analysis: All data were expressed as mean ± standard 
deviation. Statistically significant differences (P) among groups were 
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measured by one-way analysis of variance (ANOVA) and SNK post hoc 
analysis, based on normal distribution and equal variance assumption 
test. All statistical analyses were performed using SPSS v.10.1 software 
(IBM SPSS, Armonk, New York, USA). A value of P < 0.05 was considered 
statistically significant.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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